Skip to main content
. Author manuscript; available in PMC: 2005 Nov 23.
Published in final edited form as: J Clin Endocrinol Metab. 2005 Feb 15;90(5):2941–2947. doi: 10.1210/jc.2004-1314

Figure 1.

Figure 1

Fasting preinfusion concentrations of total (top) and free (bottom) IGF-I in older men (N = 8) and postmenopausal women (N = 8) pretreated for 10 days with placebo (Pl), estradiol (E2) or testosterone (Te). Data are the mean ± SEM. The P value reflects the overall interventional effect. Means with unshared (unique) alphabetic superscripts differ significantly (see Results).